A worldwide leader in injectable drug administration will be the newest company to set up shop in Greenfield, and anticipates ...

Rentschler Biopharma, a Germany-based biopharmaceuticals manufacturer with a facility in Milford, is set to produce a novel ...

Focusing on 2026 as a starting point, PwC has laid out several “strategic imperatives” pharma companies ought to pursue this ...

"PAI is a market leader in RTU oral liquid medicines, and that same focus on quality, reliability, and patient-centric design carries naturally into RTU injectables," said Kurt Orlofski, CEO of PAI ...

Contract development and manufacturing organization (CDMO) Rentschler Biopharma has announced a partnership with ...

Built-in data integrity is a bare minimum requirement in today’s BioPharmaceutical manufacturing. Good Manufacturing Practices (GMP) regulations of the Food and Drug Administration (FDA) highlight the ...

Biopharma enters 2026 amid continuing scientific progress and accelerating deal activity, yet its business model is under pressure across every facet of the value chain. Investors are taking note: ...

After a turbulent 2025, the biopharma industry is heading into the new year with major questions still unresolved. | In this ...

3M plans to invest $146 million to upgrade its biopharma filtration technology. The money will go toward facility improvements, equipment upgrades and the hiring of 60 full-time manufacturing ...

Serán Bioscience, LLC,  in collaboration with leading developer and design-builder Mortenson, hosted a topping-out ceremony ...

Mycoplasma testing is a crucial component of quality control in cell therapy studies. In clinical applications, such as those ...

As a middle schooler, you may recall learning about the Fertile Crescent of the ancient world where the Tigris and Euphrates Rivers converged. As students we may not have comprehended the importance, ...